Evidence map›Paper›PMID 25762682›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Olig1 function is required for oligodendrocyte differentiation in the mouse brain.

Jinxiang Dai, Kathryn K Bercury, Jared T Ahrendsen, Wendy B Macklin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Fisetin Mitigates Ferroptosis and Promotes Remyelination in a Cuprizone Model of Multiple Sclerosis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jinxiang DaiDepartment of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado 80045.
Kathryn K BercuryDepartment of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado 80045.
Jared T AhrendsenDepartment of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado 80045.
Wendy B MacklinDepartment of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado 80045 Wendy.Macklin@ucdenver.edu.
University of Colorado Denver · US

Funding

Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
The role of mTOR signaling in oligodendrocyte differentiation and CNS myelinationR01NS082203 · NINDS · UNIVERSITY OF COLORADO DENVER · PI MACKLIN, WENDY B, WOOD, TERESA L · 2012 to 2016
$3.3M
GLIAL SURFACE MOLECULES INVOLVED IN NEURONAL DEVELOP-F32NS008223 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI PECH, IRENE V · 1987 to 1988
–
NIGMS NIH HHS T32 GM008497NINDS NIH HHS NS08223NINDS NIH HHS R01 NS082203
6 · The paper itself

Abstract

Oligodendrocyte differentiation and myelination are tightly regulated processes orchestrated by a complex transcriptional network. Two bHLH transcription factors in this network, Olig1 and Olig2, are expressed exclusively by oligodendrocytes after late embryonic development. Although the role of Olig2 in the lineage is well established, the role of Olig1 is still unclear. The current studies analyzed the function of Olig1 in oligodendrocyte differentiation and developmental myelination in brain. Both oligodendrocyte progenitor cell commitment and oligodendrocyte differentiation were impaired in the corpus callosum of Olig1-null mice, resulting in hypomyelination throughout adulthood in the brain. As seen in previous studies with this mouse line, although there was an early myelination deficit in the spinal cord, essentially full recovery with normal spinal cord myelination was seen. Intriguingly, this regional difference may be partially attributed to compensatory upregulation of Olig2 protein expression in the spinal cord after Olig1 deletion, which is not seen in brain. The current study demonstrates a unique role for Olig1 in promoting oligodendrocyte progenitor cell commitment, differentiation, and subsequent myelination primarily in brain, but not spinal cord.

Indexed as

2',3'-Cyclic-Nucleotide PhosphodiesterasesAge FactorsAnimalsAnimals, NewbornBasic Helix-Loop-Helix ProteinsBrainCell DeathCell DifferentiationCells, CulturedGene Expression Regulation, DevelopmentalIn Vitro TechniquesMiceMice, Inbred C57BLMice, TransgenicMutationMyelin Basic Protein2',3'-Cyclic-Nucleotide PhosphodiesterasesBasic Helix-Loop-Helix ProteinsMyelin Basic ProteinMyelin-Oligodendrocyte GlycoproteinMyelin Proteolipid ProteinOlig1 protein, mouseSox2 protein, mouseSOXB1 Transcription FactorsCNSmyelinationOlig1

Identifiers

PMID25762682
PMCPMC4461695
OpenAlexW2066344417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.